Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048796635> ?p ?o ?g. }
- W3048796635 abstract "Abstract Sodium-glucose co-transporter-2 inhibitors (SGLT2i) have shown to prevent heart failure progression, although the mechanisms remain poorly understood. Here we evaluated the effect of empagliflozin (EMPA, SGLT2i) in cardiac remodeling after myocardial infarction, the interplay with diabetes status and the role of cardiac GTP enzyme cyclohydrolase 1 (cGCH1). A rat model of diabetes (50 mg/kg streptozotocin, i.p.) was subjected to myocardial infarction and left ventricular systolic dysfunction, by ligation of the left anterior descending coronary artery. EMPA therapy significantly improved cardiac remodeling parameters and ameliorated processes of fibrosis and hypertrophy, in both non-diabetic and diabetic rats. This cardioprotective effect related with a significant increase in myocardial expression levels of cGCH1, which led to activation of nNOS and eNOS, and inhibition of iNOS, and subsequently resulted in increasing of NO levels and decreasing O 2 .- and nitrotyrosine levels. These effects were replicated in a cardiomyocyte biomechanical stretching diabetic model, where silencing cGCH1 blocked the preventive effect of EMPA. The beneficial effects were observed irrespective of diabetes status, although the magnitude was greater in presence of diabetes. Empagliflozin improves myocardial remodeling after myocardial infarction through overexpression of cGCH1, and irrespective of diabetes status." @default.
- W3048796635 created "2020-08-18" @default.
- W3048796635 creator A5003356137 @default.
- W3048796635 creator A5015760911 @default.
- W3048796635 creator A5024824704 @default.
- W3048796635 creator A5048261069 @default.
- W3048796635 creator A5050414265 @default.
- W3048796635 creator A5060219163 @default.
- W3048796635 creator A5067397221 @default.
- W3048796635 creator A5085294412 @default.
- W3048796635 date "2020-08-11" @default.
- W3048796635 modified "2023-10-17" @default.
- W3048796635 title "Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status" @default.
- W3048796635 cites W1932640386 @default.
- W3048796635 cites W1971758358 @default.
- W3048796635 cites W1995484787 @default.
- W3048796635 cites W2007374852 @default.
- W3048796635 cites W2010687118 @default.
- W3048796635 cites W2028169530 @default.
- W3048796635 cites W2047770461 @default.
- W3048796635 cites W2069153850 @default.
- W3048796635 cites W2074176407 @default.
- W3048796635 cites W2077411280 @default.
- W3048796635 cites W2085015828 @default.
- W3048796635 cites W2102641536 @default.
- W3048796635 cites W2114719488 @default.
- W3048796635 cites W2144661518 @default.
- W3048796635 cites W2146190354 @default.
- W3048796635 cites W2146264128 @default.
- W3048796635 cites W2158968180 @default.
- W3048796635 cites W2159938243 @default.
- W3048796635 cites W2322058666 @default.
- W3048796635 cites W2401288519 @default.
- W3048796635 cites W2425439584 @default.
- W3048796635 cites W2558033172 @default.
- W3048796635 cites W2620926777 @default.
- W3048796635 cites W2626446274 @default.
- W3048796635 cites W2745294544 @default.
- W3048796635 cites W2775930384 @default.
- W3048796635 cites W2782327081 @default.
- W3048796635 cites W2800357110 @default.
- W3048796635 cites W2805041433 @default.
- W3048796635 cites W2805524759 @default.
- W3048796635 cites W2887650349 @default.
- W3048796635 cites W2898779626 @default.
- W3048796635 cites W2900413769 @default.
- W3048796635 cites W2913619273 @default.
- W3048796635 cites W2916824239 @default.
- W3048796635 cites W2921906047 @default.
- W3048796635 cites W2939334008 @default.
- W3048796635 cites W2943788550 @default.
- W3048796635 cites W2947319348 @default.
- W3048796635 cites W2965056983 @default.
- W3048796635 cites W2974260792 @default.
- W3048796635 cites W2982075999 @default.
- W3048796635 cites W4232534952 @default.
- W3048796635 doi "https://doi.org/10.1038/s41598-020-70454-8" @default.
- W3048796635 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7419540" @default.
- W3048796635 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32782412" @default.
- W3048796635 hasPublicationYear "2020" @default.
- W3048796635 type Work @default.
- W3048796635 sameAs 3048796635 @default.
- W3048796635 citedByCount "18" @default.
- W3048796635 countsByYear W30487966352020 @default.
- W3048796635 countsByYear W30487966352021 @default.
- W3048796635 countsByYear W30487966352022 @default.
- W3048796635 countsByYear W30487966352023 @default.
- W3048796635 crossrefType "journal-article" @default.
- W3048796635 hasAuthorship W3048796635A5003356137 @default.
- W3048796635 hasAuthorship W3048796635A5015760911 @default.
- W3048796635 hasAuthorship W3048796635A5024824704 @default.
- W3048796635 hasAuthorship W3048796635A5048261069 @default.
- W3048796635 hasAuthorship W3048796635A5050414265 @default.
- W3048796635 hasAuthorship W3048796635A5060219163 @default.
- W3048796635 hasAuthorship W3048796635A5067397221 @default.
- W3048796635 hasAuthorship W3048796635A5085294412 @default.
- W3048796635 hasBestOaLocation W30487966351 @default.
- W3048796635 hasConcept C126322002 @default.
- W3048796635 hasConcept C134018914 @default.
- W3048796635 hasConcept C164705383 @default.
- W3048796635 hasConcept C2775887513 @default.
- W3048796635 hasConcept C2777180221 @default.
- W3048796635 hasConcept C2777420927 @default.
- W3048796635 hasConcept C2777622882 @default.
- W3048796635 hasConcept C2778198053 @default.
- W3048796635 hasConcept C2778326061 @default.
- W3048796635 hasConcept C2779537366 @default.
- W3048796635 hasConcept C500558357 @default.
- W3048796635 hasConcept C519581460 @default.
- W3048796635 hasConcept C555293320 @default.
- W3048796635 hasConcept C71924100 @default.
- W3048796635 hasConceptScore W3048796635C126322002 @default.
- W3048796635 hasConceptScore W3048796635C134018914 @default.
- W3048796635 hasConceptScore W3048796635C164705383 @default.
- W3048796635 hasConceptScore W3048796635C2775887513 @default.
- W3048796635 hasConceptScore W3048796635C2777180221 @default.
- W3048796635 hasConceptScore W3048796635C2777420927 @default.
- W3048796635 hasConceptScore W3048796635C2777622882 @default.
- W3048796635 hasConceptScore W3048796635C2778198053 @default.
- W3048796635 hasConceptScore W3048796635C2778326061 @default.